Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Bevacizumab 112 Fluorouracil 97 Oxaliplatin 96 Leucovorin 95 Irinotecan 85 Capecitabine 73 Cetuximab 63 Panitumumab 42 pembrolizumab 36 regorafenib 28 Nivolumab 22 IFL protocol 21 Folfox protocol 21 trifluridine tipiracil drug combination 14 Radiotherapy 13 durvalumab 11 Gemcitabine 10 Celecoxib 9 tremelimumab 7 binimetinib 7 aflibercept 7 Drug Therapy 7 Disulfides 7 Cyclophosphamide 7 Trifluridine 6 Trastuzumab 6 Sunitinib 6 Immunoglobulin G 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡